Clinical Trial of BMS-986504 in Recurrent GBM Patients

Clinical trial NCT06883747 · RECRUITING

Trial details

NCT number: NCT06883747
Sponsor: Nader Sanai
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma WHO Grade IV

Start date: 2025-04-28
Primary completion: 2026-09-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.